rs2287371

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The ENST00000484549.6(CEP41):​n.-5A>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.423 in 1,611,662 control chromosomes in the GnomAD database, including 148,038 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 12784 hom., cov: 33)
Exomes 𝑓: 0.43 ( 135254 hom. )

Consequence

CEP41
ENST00000484549.6 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.891

Publications

20 publications found
Variant links:
Genes affected
CEP41 (HGNC:12370): (centrosomal protein 41) This gene encodes a centrosomal and microtubule-binding protein which is predicted to have two coiled-coil domains and a rhodanese domain. In human retinal pigment epithelial cells the protein localized to centrioles and cilia. Mutations in this gene have been associated with Joubert Syndrome 15; an autosomal recessive ciliopathy and neurological disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2012]
CEP41 Gene-Disease associations (from GenCC):
  • Joubert syndrome 15
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with ocular defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 7-130440971-T-G is Benign according to our data. Variant chr7-130440971-T-G is described in ClinVar as Benign. ClinVar VariationId is 261053.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.643 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP41NM_018718.3 linkc.-5A>C 5_prime_UTR_variant Exon 1 of 11 ENST00000223208.10 NP_061188.1 Q9BYV8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP41ENST00000223208.10 linkc.-5A>C 5_prime_UTR_variant Exon 1 of 11 1 NM_018718.3 ENSP00000223208.4 Q9BYV8-1

Frequencies

GnomAD3 genomes
AF:
0.401
AC:
60889
AN:
151990
Hom.:
12758
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.309
Gnomad AMI
AF:
0.451
Gnomad AMR
AF:
0.503
Gnomad ASJ
AF:
0.463
Gnomad EAS
AF:
0.662
Gnomad SAS
AF:
0.560
Gnomad FIN
AF:
0.372
Gnomad MID
AF:
0.379
Gnomad NFE
AF:
0.402
Gnomad OTH
AF:
0.435
GnomAD2 exomes
AF:
0.458
AC:
114309
AN:
249758
AF XY:
0.458
show subpopulations
Gnomad AFR exome
AF:
0.302
Gnomad AMR exome
AF:
0.578
Gnomad ASJ exome
AF:
0.466
Gnomad EAS exome
AF:
0.658
Gnomad FIN exome
AF:
0.373
Gnomad NFE exome
AF:
0.402
Gnomad OTH exome
AF:
0.418
GnomAD4 exome
AF:
0.425
AC:
620347
AN:
1459554
Hom.:
135254
Cov.:
43
AF XY:
0.428
AC XY:
310923
AN XY:
726204
show subpopulations
African (AFR)
AF:
0.303
AC:
10137
AN:
33470
American (AMR)
AF:
0.567
AC:
25357
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.460
AC:
12027
AN:
26128
East Asian (EAS)
AF:
0.666
AC:
26427
AN:
39694
South Asian (SAS)
AF:
0.547
AC:
47214
AN:
86242
European-Finnish (FIN)
AF:
0.378
AC:
19603
AN:
51872
Middle Eastern (MID)
AF:
0.382
AC:
2203
AN:
5764
European-Non Finnish (NFE)
AF:
0.406
AC:
450959
AN:
1111310
Other (OTH)
AF:
0.438
AC:
26420
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
20669
41337
62006
82674
103343
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14264
28528
42792
57056
71320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.401
AC:
60964
AN:
152108
Hom.:
12784
Cov.:
33
AF XY:
0.405
AC XY:
30127
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.310
AC:
12859
AN:
41502
American (AMR)
AF:
0.504
AC:
7706
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.463
AC:
1604
AN:
3468
East Asian (EAS)
AF:
0.661
AC:
3408
AN:
5152
South Asian (SAS)
AF:
0.560
AC:
2698
AN:
4816
European-Finnish (FIN)
AF:
0.372
AC:
3937
AN:
10586
Middle Eastern (MID)
AF:
0.394
AC:
115
AN:
292
European-Non Finnish (NFE)
AF:
0.402
AC:
27297
AN:
67976
Other (OTH)
AF:
0.440
AC:
930
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1920
3840
5760
7680
9600
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
596
1192
1788
2384
2980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.409
Hom.:
47326
Bravo
AF:
0.408
Asia WGS
AF:
0.652
AC:
2262
AN:
3478
EpiCase
AF:
0.406
EpiControl
AF:
0.400

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Joubert syndrome 15 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
18
DANN
Benign
0.92
PhyloP100
0.89
PromoterAI
0.13
Neutral
Mutation Taster
=147/153
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2287371; hg19: chr7-130080812; COSMIC: COSV56221342; COSMIC: COSV56221342; API